• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. XTENDOBUTTON ROUND MD17 DIA 7.5 PEG; RETENTION DEVICE, SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. XTENDOBUTTON ROUND MD17 DIA 7.5 PEG; RETENTION DEVICE, SUTURE Back to Search Results
Model Number 71935602
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 10/02/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Internal complaint reference (b)(4).
 
Event or Problem Description
(b)(6).It was reported that after acl surgery with xtendobutton round md17 dia 7.5 peg and ultrabutton adjustable fixation device, the patient developed deep vein thrombosis.The condition was treated with medication (apixaban and aspirin), therapy and rest.The patient recovered successfully.
 
Additional Manufacturer Narrative
Internal complaint reference (b)(4).
 
Event or Problem Description
Study id: xtendobutton, clinical study: pmcf.2018.12, subject id: 12.006, ae#01: dvt.It was reported that after a acl surgery performed on 2/10/2019 with xtendobutton round md17 dia 7.5 peg and ultrabutton adjustable fixation device, the patient developed thrombus in one of the posterior tibial veins from 10 to 5cm below the knee crease, both peroneal veins from 20 to 10cm below the knee crease, and soleal vein from 22 to 6 cm below the knee crease and phasic flow was seen in the popliteal vein and above identified on 10/10/2019.Then on 18/10/2019 there was an improvement in the venous thrombosis of the soleal and posterior tibial veins, but the thrombus still persisted in the soleal vein.Then on 13/11/2019 there was noticed a short segment thrombus in one of 2 posterior tibial veins but this was a mild improvement of the calf dvt, there was no deterioration or proximal propagation.The condition was treated with medication(apixaban and aspirin), therapy and rest.The patient has being recovered and its now waiting another monitoring visit on 27-28 of april 2021.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
 
Additional Manufacturer Narrative
Internal complaint reference (b)(4).H3, h6: the reported device, used in treatment, was not returned to the designated complaint unit for independent evaluation, thus visual inspection and functional testing could not be performed.A review of the device history records showed there were no indications to suggest that the product did not meet manufacturing specification or would not be able to perform as intended.A complaint history review concluded this was a isolated event.The instructions for use was reviewed and found to include conditions of off label use and technique specifics, as well as precautions and warnings related to the use of the device.A review of risk management files found that the reported failure was documented appropriately.A review of the complaint revealed the patient recovered from the reported injuries successfully and there is no longer an apparent patient impact based on the details provided.Therefore, no further medical assessment is warranted.A relationship, if any, between the subject device and the reported event could not be determined.Please refer to the instructions for use for recommendations on proper use of the device and potential troubleshooting methods to prevent future reoccurrence of the reported event.No containment or corrective actions are recommended at this time.If the product associated with this event is returned at a future date, this investigation will be reopened for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XTENDOBUTTON ROUND MD17 DIA 7.5 PEG
Common Device Name
RETENTION DEVICE, SUTURE
Manufacturer (Section D)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer (Section G)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key11617206
Report Number1219602-2021-00772
Device Sequence Number12974363
Product Code KGS
UDI-Device Identifier00885556702703
UDI-Public00885556702703
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number71935602
Device Catalogue Number71935602
Device Lot Number18MCT0022C
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 03/16/2021
Supplement Date Received by Manufacturer04/27/2021
11/16/2021
Initial Report FDA Received Date04/05/2021
Supplement Report FDA Received Date05/04/2021
11/17/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/22/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
THERAPY, ANTICOAGULATION THERAPY. APIXABAN/ASPIRIN; THERAPY, ANTICOAGULATION THERAPY. APIXABAN/ASPIRIN
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-